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Antimicrobial activityAbstract In this study, new isochroman-triazole (6a–e) and thiadiazole (7a–e) conjugates were
obtained by heterocyclization of isochromanyl thiosemicarbazides (5a–e) under basic and acidic
catalysis respectively. The latter were obtained by the treatment of corresponding acetohydrazide
(4) with suitably substituted phenylisothiocyanates. The acetohydrazide (4) is accessible from
methyl 2-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-1H-isochromen-1-yl)acetate (3) obtainable by
oxa-Pictet–Spengler reaction of 2-(3,4,5-trimethoxyphenyl)ethanol (2) with methyl acetoacetate in
the presence of p-TsOH. The isochromanyl triazoles (6a–e) and isochromanyl thiadiazoles (7a–e)
were screened for their in vitro antibacterial activity against four bacterial strains and were found
to exhibit moderate to good activity toward the tested microorganisms, compared to ampicillin,
the standard drug. In vitro antifungal activity was also determined against four fungal strains using
ﬂuconazole as standard and the most active compounds were identiﬁed in each case.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Isochroman (3,4-dihydro-1H-benzopyran) is among the best
known oxygen heterocycles, well represented as a structural
motif in numerous natural products for instance 1,6,8-trihy
droxy-3-heptyl-7-carboxyisochroman, [1] an antibiotic and
topoisomerase II inhibitor from the Penicillium sp.;pseudodeﬂectusin [2] a selective human cancer cytotoxin from
Aspergillus pseudodeﬂectus, softwood lignin isochromans [3]
and the male wing gland pheromone of bumble-bee wax moth
Aphomia sociella [4] and in extra-virgin olive oil [5]. Various
isochroman derivatives are known to possess an array of bio-
logical activities, including antioxidant [6], antiplatelet activity
[7] plant growth regulatory and herbicidal activities [8].
Synthetic isochromans have been shown to act as estrogen
receptor ligands [9] dopamine receptor ligands [10] and as fra-
grances such as the commercial musk odorant galaxolide [11].
A novel isochroman derivative inhibited apoptosis in vascular
endothelial cells through depressing the levels of integrin b4,
p53 and reactive oxygen species (ROS) [12].
Small heterocycle scaffold containing nitrogen, sulfur and
oxygen has been under investigation for a long time because
of their important medicinal properties. Among these types
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logical activities. 4,5-Disubstituted-2,4-dihydro-3H-1,2,4-
triazole-3-thiones are especially important due to their
biological [13] industrial and agricultural applications. A
celebrated example is that of ﬂuconazole, an antifungal agent
for the treatment of superﬁcial and systemic infections [14].
Others possess diuretic [15], antibacterial [16], hypoglycemic
[17] and antitubercular [18] activities. Moreover, these are
inhibitors of corrosion of copper, brass, aluminum and steel
in marine environment [19] and inhibitors of fog formation
in photographic emulsions [20].
Similarly the substituted-1,3,4-thiadiazoles are found to
exhibit a variety of bioactivities including antibacterial [21],
radioprotective, antitumor, gastroprotective [22], corrosion
inhibitor [23], ulcer inhibitor [24] and are used in photography
[25] and as diuretic drugs [26].
The aforesaid biological signiﬁcance of the individual hete-
rocycles namely triazoles and thiadiazoles on one hand and
those of isochromans on the other, prompted us to synthesize
some biheterocycles by molecular hybridization of these hete-
rocycles with isochroman via a methylene bridge to combine
their useful effects in a single structural unit. The diversity
can be introduced in the phenyl ring by changing the substitu-
tion (Fig. 1).OMe
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Figure 1 Designed 1-isochromanyl triazoles and thiadiazole
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2.1. Chemistry
The synthesis of title compounds was accomplished according
to synthetic route described in Scheme 1. 3,4,5-
Trimethoxyphenyl acetic acid was converted into methyl
3,4,5-trimethoxyl phenyl acetate (1) by the standard method.
The ester was reduced to corresponding phenyl ethanol (2) using
a NaBH4/MeOH mixture in dry THF [27]. Acid catalyzed oxa-
Pictet–Spengler reaction of (2) with methyl acetoacetate
afforded the methyl 2-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-
1H-isochromen-1-yl)acetate (3) [28]. FTIR carbonyl stretching
at 1731 cm1 was observed for ester carbonyl and in 1H NMR
characteristic 2H singlet at d 2.93 for CH2, 3H singlet at d
2.20 for CH3 at C-1, besides the multiplets at d 3.95 ppm for
CH2 at C-3, and C-4 and signals for ethyl moiety were noted.
The 13C NMR spectrum showed signals at d 169 for C‚O,
75.1 for C-1, and at 65.2 and 59.3 for C-3 and C-4 respectively.
The isochromanyl ester was converted into acetohydrazide
(4) by reﬂuxing with hydrazine hydrate (80%) in methanol.
The carbonyl stretching at 1734 cm1 was observed for
hydrazide in addition to stretchings for NH and NH2 at
3337, 3290–3341 cm1 respectively in FTIR spectrum. In
1H NMR disappearance of peaks due to the ester and appear-
ance of signals at 7.8–8.1 ppm for NH and 5.5–6.2 ppm for the
NH2 group were noted.
Suitably substituted aryl isothiocyanates were reﬂuxed with
acetohydrazide (4) in ethanol to afford the thiosemicarbazides
(5a–e). In IR spectra disappearance of NH2 stretching and
appearances of two new stretching for NH-1 and NH-2
protons were observed at 3200–3372 and 3261–3295 cm1. In
1H NMR signals were observed for NH-1 proton at d 8.3–
8.9 ppm, at 2.3–2.4 ppm for NH-2 at d 7.4–7.9 for NH-3 pro-
ton of the thiosemicarbazides in addition to those for the
isochroman moiety.Me
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cyclization gave N-aryl-5-((6,7,8-trimethoxy-1-methyl-3,4-
dihydro-1H-isochromen-1-yl)methyl)-1,3,4-thiadiazol-2-amines
(6a–e). IR spectra show disappearance of NH stretching and
appearance of C‚N and C–S stretching at 1346–1423, and
1231–1271 respectively, which shows ring closure. In 1H
NMR spectra disappearance of signals for NH-2 and NH-3
groups of thiosemicarbazides and appearance of one singlet
for the NH group of the isochromanyl thiadiazole group at d
7.7–8.15 ppm were observed. In 13C NMR signal at d 168–
171 for C-5 carbon and d 150–154 ppm for C-2 carbon of
the thiadiazole ring was observed.
Base catalyzed intramolecular cyclization of thiosemicar-
bazides (5a–e) afforded the triazoles (7a–e). In IR spectra dis-
appearance of NH stretching and appearance of C‚N
stretching at 1421–1598 which shows that ring closure. In 1H
NMR spectra disappearance of signals for the NH group and
appearance of one singlet for the NH group of the isochromanyl
triazole group at d 8.87–11.30 ppm show the ring closure.
2.1.1. Antibacterial activity
Antibacterial and antifungal potential of extracts was assessed
in terms of zone of inhibition of microbial growth. The newly
synthesized isochroman-triazoles (6a–e) and thiadiazoles
(7a–e) were tested for their inhibition growth against
Staphylococcus aureus (ATTC-25923), Escherichia coli
(ATTC-25922), Pseudomonas aeruginosa (ATTC-27853) and
Klebsiella pneumoniae (recultured) bacterial strains using the
disk diffusion method [29–30]. Batches of 100 disks were dis-
pensed to each screw capped bottle and sterilized by dry heat
at 140 C for 1 h. The test compounds were prepared with dif-
ferent concentrations using dimethylformamide (DMF). 1 mL
containing 100 times the amount of chemical in each disk was
added to each bottle, which contains 100 disks. The disk of
each concentration was placed in triplicate in a nutrient agar
medium separately seeded with fresh bacteria. The incubation
was carried out at 37 C for 24 h. Solvent and growth controls
were kept separate, the zones of inhibition and minimum inhi-
bitory concentration (MIC) were measured.
The results of the antibacterial and antifungal activity are
presented in Table 1 using Ampicillin as standard drug forTable 1 Antibacterial activities of the isochroman-triazoles
(6a–e) and thiadiazole (7a–e) (zone of inhibition in mm, MIC in
mg/mL given in parenthesis).
Compounds (S.a) (E.c) (P.a) (K.p)
6a 21 (30.5) 19 (30.5) 20 (30.5) 17 (30.5)
6b 19 (12.5) 17 (12.5) 17 (12.5) 18 (12.5)
6c 17 (10.5) 12 (10.5) 19 (10.5) 10 (10.5)
6d 21 (50) 21 (50) 19 (50) 6 (50)
6e 20 (6.25) 21 (6.25) 20 (6.25) 20 (6.25)
7a 18 (10.5) 19 (10.5) 21 (10.5) 19 (10.5)
7b 20 (6.25) 21 (6.25) 19 (6.25) 20 (6.25)
7c 16 (12.5) 17 (12.5) 10 (12.5) 11 (12.5)
7d 15 (12.5) 16 (12.5) 15 (12.5) 14 (12.5)
7e 21 (12.5) 20 (12.5) 19 (12.5) 17 (12.5)
Ampicillin 22 (6.25) 22 (6.25) 22 (6.25) 23 (6.25)
Abbreviations: MIC, minimum inhibitory concentration; (S.a)
Staphylococcus aureus; (E.c) Escherichia coli; (P.a) Pseudomonas
aeruginosa; (K.p) Klebsiella pneumoniae.comparison. The compounds 6e and 7b were most active
against the four bacterial strains. The remaining compounds
were found to be less active against four bacterial strains.
2.1.2. Antifungal activity
The newly synthesized compounds were investigated for their
antifungal activity against four fungal strains namely,
Aspergillus ﬂavus (NCIM No.524), Aspergillus fumigatus
(NCIM No.902), Penicillium marneffei (recultured) and
Trichophyton mentagrophytes (recultured). Sabouraud’s agar
media was prepared by dissolving peptone (1.0 g), D-Glucose
(4.0 g) and agar (2.0 g) in sterile water (100 mL) and the pH
was adjusted to 5.7. Normal saline was used to make a suspen-
sion of spores of fungal strain for learning. A loopful of partic-
ular fungal strain was transferred to 3 mL of saline to get a
suspension of corresponding species. Agar media of 20 mL
was poured into each petri dish. Excess of suspension was dec-
anted and the plates were dried by placing them in an incuba-
tor at 37 C for 1 h. Using an agar, punch wells were made on
these seeded agar plates, from 6.25 lg/mL to 100 lg/mL of the
test compounds in DMSO was added into each well labeled
disks. Controls were run using DMSO at the same concentra-
tion as used with the test compounds. The petri dishes were
prepared in triplicate and maintained at 37 C for 3–4 days.
Antifungal activity was determined by measuring the diameter
of the inhibition zone [27,28]. The results of these studies are
given in Table 2 and compared with the standard ﬂuconazole
drug. It was observed that most of the compounds exhibited
good antifungal activity. Compounds 6c and 7b showed most
antifungal activity against all the four fungal strains namely,
A. ﬂavus, A. fumigatus, P. marneffei and T. mentagrophytes.
Compounds showed good antifungal activity against various
fungal strains.
2.2. Experimental
Melting points of the compounds were measured in open cap-
illaries using Stuart melting point apparatus (SMP-3) and are
uncorrected. The IR spectra were recorded on FTS 3000Table 2 Antifungal activities of the isochroman-triazoles (6a–
e) and thiadiazole (7a–e) (zone of inhibition in mm, #MIC in
mg/mL given in parenthesis).
Compounds (T.a) (P.m) (A.ﬂ) (A.fu)
6a <10 (50) <10 (50) <10 (50) <10 (50)
6b 16 (12.5) 16 (12.5) 13 (12.5) 12 (12.5)
6c 23 (8.25) 21 (8.25) 22 (8.25) 19 (8.25)
6d 14 (12.5) 15 (12.5) 13 (12.5) 13 (12.5)
6e 17 (12.5) 16 (12.5) 15 (12.5) 14 (12.5)
7a 13 (50) 12 (50) 11 (50) 13 (50)
7b 21 (6.25) 20 (6.25) 21 (6.25) 20 (6.25)
7c 16 (12.5) 17 (12.5) 15 (12.5) 13 (12.5)
7d 15 (12.5) 16 (12.5) 14 (12.5) 14 (12.5)
7e 16 (12.5) 14 (12.5) 13 (12.5) 14 (12.5)
Fluconazole 23 (6.25) 24 (6.25) 21 (6.25) 22 (6.25)
Abbreviations: # MIC: minimum inhibitory concentration. The
lowest concentrations of the compounds that inhibit the growth of
the tested microorganism. (T.a) Trichophyton mentagrophytes;
(P.m) Penicillium marneffei; (A.ﬂ) Aspergillus ﬂavus; (A.fu) Asper-
gillus fumigatus.
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1H NMR spectra were determined as CDCl3 solutions at
300 MHz using a Bruker AM-300 spectrophotometer using
TMS as an internal reference and 13C NMR spectra were
determined at 75 MHz using a Bruker 75 MHz NMR in
CDCl3 or CD3OD and mass spectra (EI, 70 eV) on a GC–
MS instrument. The elemental analyses were conducted using
a LECO-183 CHNS analyzer. The Rf values were determined
using aluminum pre-coated silica gel plates Kiesel 60 F254 from
Merck (Germany).
2.2.1. Synthesis of methyl-3,4,5-trimethoxyphenylacetic acid
ester (1)
Methyl ester of 3,4,5-trimethoxyphenyl acetic acid was synthe-
sized by reﬂuxing in methanol in the presence of a few drops of
acid. Yield: 62%; oil; Rf (Pet. ether: ethyl acetate, 9:1): 0.5;
FTIR (cm1): 2919, 2910, 1732, 1461, 1235, 1012; 1H NMR
(CDCl3): d 6.01 (s, 1H Ar), 3.90 (s, 9H, 3 · OCH3), 3.71 (s,
3H, OCH3), 3.32 (s, 2H, CH2) ppm;
13C NMR (CDCl3): d
169.2 (C‚O), 151.0, 147.2, 146.1, 145.0, 129.4, 107.0, 65.6,
59.8, 56.1 ppm.
2.2.2. 2-(3,4,5-Trimethoxyphenyl)ethanol (2)
Methyl ester of 3,4,5-trimethoxyphenyl acetic acid was reduced
into 3,4,5-trimethoxy phenylethyl alcohol by reﬂuxing with
sodium borohydride and methanol in tetrahydrofuran accord-
ing to procedure reported by us earlier [27].
Yield: 62%; (oil); Rf (Petroleum ether: ethyl acetate, 9:1):
0.3; Elemental analysis for C12H10N2O3S (MW= 316.19) in
wt% calc. C = 60.74, H = 8.92 and found to be C = 60.87,
H = 8.89, N = 10.41, S = 12.50; FTIR (cm1): 2919, 2910,
1732, 1461, 1235, 1012; 1H NMR (CDCl3): d 6.41 (s, 1H
Ar), 3.92 (s, 9H, 3 · OCH3), 3.11 (m, 2H, OCH2CH2), 2.94
(m, 2H, OCH2CH2),
13C NMR (CDCl3): d 169.2 (C‚O),
151.1, 147.7, 146.1, 145.8, 129.7, 107.8, 65.1, 61.7, 59.8,
56.0 ppm; EIMS m/z: 262 M+ (100%), 247, 219, 177, 151,
135, 119, 109, 77, 65, 43 ppm.
2.2.3. Synthesis of methyl 2-(6,7,8-trimethoxy-1-methyl-3,4-
dihydro-1H-isochromen-1-yl)acetate (3)
Methyl acetoacetate was added to a stirred solution of 2-(3,4,5-
trimethoxyphenyl)ethanol (2) in dry benzene. A catalytic
amount of p-toluenesulfonic acid was added to the ﬂask ﬁtted
with Dean–Stark trap and the reaction mixture was reﬂuxed
for 12 h. On completion (TLC) the solvent was removed under
reduced pressure affording a pale yellow oil, which was dis-
solved in ethyl acetate and subjected to TLC chromatography
(Petroleum ether: Ethyl acetate, 9:1) to afford the ester (3)
Yield: 79%; (oil); Rf (Petroleum ether: ethyl acetate, 9:1):
0.4; Elemental analysis for C12H10N2O3S (MW= 316.19) in
wt% calc. C = 60.74, H = 8.92 and found to be C = 60.87,
H = 8.89; IR (cm1): 2930, 1731, 1467, 1235, 1025; 1H
NMR (CDCl3): d 6.51 (s, 1H Ar, H-5), 4.11 (q, 3H,
OCH2CH3, J= 3.5), 3.95 (m, 2H, H-3), 3.91 (s, 9H,
3 · OCH3), 2.93 (s, 2H, H-11), 2.65 (m, 2H, H-4), 2.23 (s,
3H, H-13), 1.37 (t, 3H, OCH2CH3 J= 3.5) ppm;
13C NMR
(CDCl3): d 169.1 (C‚O), 146.8, 148.3, 146.1, 136.6, 128.7,
124.3, 10.1, 75.0 (C-1), 65.2 (C-3), 59.7 (C-4), 56.7
(3 · OCH3), 48.7, 32.6 (C-11), 25.4 ppm; EIMS m/z: 316 M+
(100%), 285, 31.2.2.4. 2-(6,7,8-Trimethoxy-1-methyl-3,4-dihydro-1H-
isochromen-1-yl)acetohydrazide (4)
To an ethanolic solution of isochromanyl acetate (3), 85%
hydrazine hydrate was added and reﬂuxed for 72 h. At the
end the resulting mixture was concentrated and cold water
was added in it. The solid product was separated, ﬁltered,
dried and subjected to recrystallization from methanol.
Yield: 78%; 164–165 C; Rf (Petroleum ether: ethyl acetate,
9:1): 0.1; Elemental analysis for C15H28N2O5 (MW= 316.19)
in wt% calc. C = 56.94, H = 8.92, N = 8.85 and found to
be C = 56.99, H = 9.01, N = 8.91; IR (cm1): 3372, 3295,
1655, 1459, 1247; 1H NMR (CDCl3): 7.71 (bs, 1H, NH),
6.46 (s, 1H, H-5), 3.99 (m, 2H, H-3), 3.92 (s, 9H, 3 · OCH3),
3.07 (s, 2H, H-11), 2.61 (m, 2H, H-4), 1.98 (s, 3H, H-13)
ppm; 13C NMR (CDCl3): 169.1 (CO), 146.4, 148.7, 146.1,
136.4, 128.6, 124.8, 105.0, 75.4 (C-1), 65.3, 59.1, 56.4.
(3 · OCH3), 48.3 ppm; EIMS m/z: 316 M+ (100%), 285, 257,
31.
2.2.5. Synthesis of 4-aryl-1-(2-(6,7,8-trimethoxy-1-methyl-3,4-
dihydro-1H-isochromen-1-yl)acetyl) thiosemicarbazides (5a–
e), General procedure
To a solution of isochromanylacetyl hydrazide (4) in absolute
ethanol (30 mL) a solution of substituted phenylisothio-
cyanates (6.6 mmol) in ethanol (10 mL), was added dropwise
with continuous stirring. The reaction mixture was reﬂuxed
for 6 h and monitored by TLC. On completion, the mixture
was cooled to room temperature and the solvent was rotary
evaporated leaving a solid product, recrystallized from a mix-
ture of ethyl acetate and petroleum ether (4:1) to yield the
thiosemicarbazides (5a–e).
2.2.6. 1-(1-Methyl-6,7,8-trimethoxy)isochromanyl-20-methoxy
phenyl thiosemicarbazide (5a)
Yield: 73%;semisolid, Rf (Petroleum ether: ethyl acetate, 1:9):
0.5; Elemental analysis for C23H35N3O6S (MW= 481) in wt%
calc. C = 57.36, H = 7.33, N = 8.73, S = 6.66 and found to
be C = 57.49, H = 7.43, N = 8.99, S = 6.69; FTIR (cm1):
3272, 3261, 1634, 1451, 1232; 1H NMR (CDCl3): d 8.32 (s,
1H, NH), 7.93 (s, 1H, NH), 7.81 (d, 1H Ar, J = 3.2), 7.61
(d, 1H Ar, H-50, J = 5.5), 7.43 (d, 1H Ar, H-40, J = 3.2),
7.11 (d, 1H Ar, J = 6.1), 6.55 (s, 1H Ar, H-50), 6.4 (s, 1H
Ar, H-4), 3.96 (m, 2H, H-30), 3.91 (s, 9H, 3 · OCH3), 3.07 (s,
2H, H-11), 2.53 (m, 2H, H-4), 1.81 (s, 6H, 2 · CH3), 1.52 (s,
3H, H-13) ppm; 13C NMR (CDCl3): d 181.5 (CS), 177.7
(CO), 158.6 (C-20), 149.0 (C-8), 148.8 (C-6), 136.4 (C-7),
128.3 (C-10), 127.6 (C-60), 121.6 (C-9, C-50), 114.7 (C-30),
75.9 (C-1), 65.0 (OCH3), 60.1 (C-3), 47.0 (CH2), 27.4 (CH3)
ppm; EIMS m/z: 482 M+ (100%), 315, 285, 257, 196, 166.
2.2.7. (1-Methyl-6,7,8-trimethoxy)isochromanyl-40-methyl
phenyl thiosemicarbazide (5b)
Yield: 82%; (semisolid): Rf (Petroleum ether: ethyl acetate,
1:9): 0.8; Elemental analysis for C23H35N3O5S (MW= 465)
in wt% calc. C = 57.33, H = 7.58, N = 9.02, S = 6.89 and
found to be C = 57.41, H = 7.54, N = 8.99, S = 6.92;
FTIR (cm1): 3345, 3295, 1636, 1491, 1264; 1H NMR
(CDCl3): d 8.32 (bs, NH), 7.40 (d, 2H Ar, H-30,50, J = 5.3),
7.28 (d, 2H Ar, H-20,60, J= 4.8), 7.11 (bs, NH), 6.50 (s, 1H,
H-5), 3.91 (s, 9H, 3 · OCH3), 3.81 (m, 2H, H-3), 3.73 (s, 2H,
190 A. Saeed, A. MumtazH-11), 2.43 (m, 2H, H-4), 1.69 (s, 3H, CH3), 1.52 (s, 3H, CH3)
ppm; 13C NMR (CDCl3): d 181.4 (C‚S), 177.4 (CO), 149.9
(C-8), 148.7 (C-6), 136.8 (C-7), 129.4 (C-30, C-50), 128.9 (C-
10), 126.3 (C-20, C-60), 121.5 (C-9), 75.4 (C-1), 65.0
(3 · OCH3), 60.7 (C-3), 47.1 (CH2), 27.3 (CH3) ppm; EIMS
m/z: 465 M+ (100%), 315, 285, 180, 150.
2.2.8. 1-(1-Methyl-6,7,8-trimethoxy)isochromanyl-40-methoxy
phenyl thiosemicarbazide (5c)
Yield: 77%; (semisolid): Rf (Petroleum ether: ethyl acetate,
1:9): 0.8; Elemental analysis for C23H35N3O6S (MW= 481)
in wt% calc. C = 57.36, H = 7.33, N = 8.73, S = 6.66 and
found to be C = 57.49, H = 7.43, N = 8.99, S = 6.69;
FTIR (cm1): 3314, 3288, 1651, 1467, 1246; 1H NMR
(CDCl3): d 8.43 (bs, NH), 7.81 (s, NH), 7.31 (d, 2H Ar,
H-30,50, J = 5.1), 6.90 (d, 2H Ar, H-20,60, J= 5.5), 6.51 (s,
1H Ar, H-5), 4.02 (m, 2H, H-3), 3.84 (s, 12H, 4 · OCH3),
3.72 (s, 2H, H-11), 2.91 (m, 2H, H-4), 2.29 (s, 3H, H-13),
1.58 (s, 3H, CH3) ppm;
13C NMR (CDCl3): d 181.8
(C‚S), 177.2 (CO), 149.4 (C-8), 148.3 (C-6), 136.7 (C-7),
129.4 (C-30, C-50), 128.9 (C-10), 126.3 (C-20, C-60), 121.6
(C-9), 75.2 (C-1), 65.3 (3OCH3), 62,0 (OCH3), 60.1 (C-3),
47.9 (CH2), 27.1 (CH3) ppm. EIMS m/z: 465 M
+ (100%),
315, 285, 180, 150.
2.2.9. 1-(1-Methyl-6,7,8-trimethoxy)isochromanyl-40-
chlorophenylthiosemicarbazide (5d)
Yield: 80%; semisolid, Rf (Petroleum ether: ethyl acetate, 1:9):
0.8; Elemental analysis for C22H32ClN3O6S (MW= 485) in
wt% calc. C = 54.37, H = 6.64, N = 8.65, S = 6.60 and
found to be C = 54.41, H = 6.74, N = 8.78, S = 6.69;
FTIR (cm1): 3326, 3281, 1634, 1461, 1223; 1H NMR
(CDCl3): d 8.91 (bs, NH), 7.94 (s, NH), 7.53 (d, 2H Ar, H-
30,50, J= 5.3), 7.32 (d, 2H Ar, H-20,60, J= 4.9), 6.30 (s, 1H
Ar, H-5), 3.93 (s, 9H, 3 · OCH3), 3.81 (m, 2H, H-3), 3.71 (s,
2H, H-11), 2.91 (m, 2H, H-4), 2.20 (s, 3H, H-13) ppm. 13C
NMR (CDCl3): d 181.3 (CS), 177.6 (CO), 149.8. (C-8), 148.0
(C-6), 136.0 (C-7), 131.4 (C-40), 130.5 (C-30, C-50), 129.6 (C-
10), 126.7 (C-20, C-60), 121.5 (C-9), 75.8 (C-1), 65.4
(3 · OCH3), 60.7 (C-3), 47.3 (CH2), 27.2 (CH3) ppm; EIMS
m/z: 485 M+ (100%), 315, 285, 180, 169.
2.2.10. 1-(1-Methyl-6,7,8-trimethoxy)isochromanyl-30-methoxy
phenyl thiosemicarbazide (5e)
Yield: 86%; semisolid, Rf (Petroleum ether: ethyl acetate, 1:9):
0.8; Elemental analysis for C23H35N3O6S (MW= 481) in wt%
calc. C = 57.36, H = 7.33, N = 8.73, S = 6.66 and found to
be C = 57.49, H = 7.43, N = 8.99, S = 6.69; IR (cm1):
3372, 3295, 1663, 1462, 1242, 1H NMR (CDCl3): d 8.45 (bs,
NH), 7.67 (s, NH), 7.33 (d, 1H Ar, H-50, 4.3), 7.11 (d, 1H
Ar, H-40, J= 4.2), 6.50 (d, 1H Ar, H-5, J= 3.3), 6.43 (d,
1H Ar, H-20, J= 3.9), 6.31 (s, 1H Ar, H-60), 3.92 (s, 9H,
3 · OCH3), 3.83 (m, 2H, H-3), 3.71 (s, 2H, H-11), 2.91 (m,
2H, H-4), 2.2 (s, 3H, H-13) ppm; 13C NMR (CDCl3): d
181.4 (C‚S), 177.3 (C‚O), 162.2 (C-30), 149.4 (C-8), 148.1
(C-6), 140.0 (C-1), 136.7 (C-7), 131.2 (C-40), 129.5 (C-10),
126.1 (C-20, C-60), 121.2 (C-9), 118.5 (C-50), 104.7 (C-5), 75.1
(C-1), 65.0 (3 · OCH3), 64.3 (OCH3), 60.4 (C-3), 47.4 (CH2),
27.4 (CH3) ppm; EIMS m/z: 465 M
+ (100%), 315, 285,
180, 150.2.2.11. Synthesis of N-(phenyl)-5-(6,7,8-trimethoxy-1-methyl-
3,4-dihydro-1H-isochromen-1-yl)-1,3,4-thiadiazole-2-amines
(6-e)
Thiosemicarbazides (5a–e) were added portion wise to cooled
sulfuric acid at 0 C with constant stirring. After completion
addition the reaction mixture was stirred further for 3 h, and
then allowed to stand for overnight. The reaction mixture
was poured onto the crushed ice. The solid products (6-e)
obtained were puriﬁed by recrystallization from ethanol–water.
2.2.12. N-(2-methoxyphenyl)-5-(6,7,8-trimethoxy-1-methyl-
3,4-dihydro-1H-isochromen-1-yl)-1,3,4-thiadiazole-2-amine
(6a)
Yield: 80%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
0.6; Elemental analysis for C23H33N3O5S (MW= 481) in wt%
calc. C = 59.59, H = 7.17, N = 9.06, S = 6.92 and found to
be C = 59.61, H = 7.28, N = 9.13, S = 7.01; FTIR (cm1):
3193, 1625, 1423, 1231; 1H NMR (CDCl3): d 7.71 (bs, NH),
7.5 (d, 1H Ar, J = 3.2), 7.3(d, 1H Ar, J = 5.5), 7.12 (d, 1H
Ar, J = 3.2), 6.50 (s, 1H Ar), 3.90 (s, 12H, 4 · OCH3), 3.82
(m, 2H, H-3), 3.74 (s, 2H, H-11), 2.91 (m, 2H, H-4), 2.20 (s,
3H, H-13) ppm; 13C NMR (CDCl3): d 170.2 (C5N), 154.0
(C2–N), 148.2 (C-6
0, C-80), 146.9 (C-200), 134.8 (C-70), 133.4
(C-100), 128.7 (C-100), 124.8 (C-90), 122.2 (C-400), 116.9 (C-500),
112.7 (C-400), 105 (C-50), 70.6 (C-30), 65.7 (3 · OCH3), 63.3
(OCH3), 35.6 (C-4
0), 26.9, 23.0 ppm; EIMS m/z: 463 M+
(100%), 356, 341, 297, 165,122, 107.
2.2.13. N-(4-methylphenyl)-5-(6,7,8-trimethoxy-1-methyl-3,4-
dihydro-1H-isochromen-1-yl)-1,3,4-thiadiazole-2-amine (6b)
Yield: 83%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
(0.7); Elemental analysis for C23H33N3O4S (MW= 481) in
wt% calc. C = 61.72, H = 7.43, N = 9.39, S = 7.16 and
found to be C = 61.88, H = 7.59, N = 9.45, S = 7.25;
FTIR (cm1): 3305, 1617, 1367, 1271; 1H NMR (CDCl3): d
8.0 (bs, NH), 7.3 (d, 2H Ar, J= 5.6), 7.22 (d, 2H Ar,
J = 4.3), 6.5 (s, 1H,H-5), 3.9 (s, 9H, 3 · OCH3), 3.84 (m,
2H, H-3), 3.7 (s, 2H, H-11), 2.5 (m, 2H, H-4), 2.3 (s, 3H,
CH3), 1.6 (s, 3H, CH3) ppm;
13C NMR (CDCl3): d 168.3
(C5N), 153.3 (C2N), 148.4 (C-6
0, C-80), 141.9 (C-100), 134.5
(C-70), 130.7 (C-300, C-500), 129.8, (C-400), 128.3 (C-100), 124.3
(C-90), 113.9 (C-200, C-400), 105.9 (C-50), 70.1 (C-30), 65.0
(3 · OCH3), 63.8 (OCH3), 3.75 (C-40), 26.8, 23.4 ppm; EIMS
m/z: 463 M+ (100%), 341, 297, 150, 106.
2.2.14. Synthesis of N-(4-methoxyphenyl)-5-(6,7,8-trimethoxy-
1-methyl-3,4-dihydro-1H-isochromen-1-yl)-1,3,4-thiadiazole-2-
amine (6c)
Yield: 77%; semisolid, Rf (Petroleum ether: ethyl acetate, 1:9):
0.8; Elemental analysis for C23H33N3O5S (MW= 481) in wt%
calc. C = 59.59, H = 7.17, N = 9.06, S = 6.92 and found to
be C = 59.61, H = 7.28, N = 9.13, S = 7.01; FTIR (cm1):
3315, 1622, 1343, 1272; 1H NMR (CD3OD): d 8.11 (bs,
NH), 7.73 (d, H Ar, J= 5.2), 7.43 (d, 2H Ar, J= 5.3), 6.5
(s, 1H, H-5), 3.92 (m, 2H, H-3), 3.84 (s, 12H, 4 · OCH3),
3.72 (s, 2H, H-11), 2.9 (m, 2H, H-4), 2.21 (s, 3H, H-13), 1.52
(s, 3H, CH3) ppm;
13C NMR (CD3OD): d 169.0 (C5N),
155.4 (C2N), 148.1 (C-6
0, C-80), 141.4 (C-100), 134.5 (C-70),
130.8 (C-300, C-500), 129.7 (C-400), 128.8 (C-100), 124.1 (C-90),
113.4 (C-200, C-400), 105.7 (C-50), 70.4 (C-30), 65.7 (3 · OCH3),
Novel isochroman-triazoles and thiadiazole hybrids 19161 (OCH3), 35 (C-4
0), 26.8, 23.4 ppm;; EIMS m/z: 463 M+
(100%), 341, 297, 166, 122.
2.2.15. N-(4-chlorophenyl)-5-(6,7,8-trimethoxy-1-methyl-3,4-
dihydro-1H-isochromen-1-yl)-1,3,4-thiadiazole-2-amine (6d)
Yield: 81%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
0.8; Elemental analysis for C22H30ClN3O4S (MW= 481) in
wt% calc. C = 56.46, H = 6.46, N = 8.98, S = 6.85 and
found to be C = 56.57, H = 6.58, N = 9.02, S = 8.93;
FTIR (cm1): 3294, 1632, 1359, 1254, 1H NMR (CD3OD): d
8.1 (bs, NH), 7.8 (d, 2H Ar, J= 5.0), 7.5 (d, 2H Ar,
J= 5.0), 6.44 (s, 1H, H-5), 3.92 (s, 9H, 3 · OCH3), 3.85 (m,
2H, H-3), 3.71 (s, 2H, H-11), 2.93 (m, 2H, H-4), 2.21 (s, 3H,
H-13) ppm; 13C NMR (CD3OD): d 171.0 (C5N), 152.3
(C2N), 148.8 (C-6
0, C-80), 141.6 (C-100), 136.5 (C-300, C-500),
134 (C-70), 129.8 (C-400), 128.7 (C-100), 124.5 (C-90), 121.4 (C-
200, C-400), 105.1 (C-50), 70.2 (C-30), 65.4 (3 · OCH3), 61.2
(OCH3), 35.5 (C-4
0), 26.7, 23.4 ppm; EIMS m/z: 465 M+
(100%), 341, 297, 169, 126.
2.2.16. N-(3-methoxyphenyl)-5-(6,7,8-trimethoxy-1-methyl-
3,4-dihydro-1H-isochromen-1-yl)-1,3,4-thiadiazole-2-amine
(6e)
Yield: 86%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
0.5; Elemental analysis for C23H33N3O5S (MW= 481) in wt%
calc. C = 59.59, H = 7.17, N = 9.06, S = 6.92 and found to
be C = 59.61, H = 7.28, N = 9.13, S = 7.01; FTIR (cm1):
32,785, 1589, 1346, 1256, 1H NMR (CD3OD): d 8.15 (bs,
NH), 7.7 (s, 1H), 7.66 (d, 1H Ar, J = 4.5), 7.32 (d, 1H Ar,
J= 4.5), 6.6 (d, 1H Ar, J= 3.2), 6.43 (s, 1H, H-5), 3.9 (s,
9H, 3 · OCH3), 3.87 (m, 2H, H-3), 3.75 (s, 2H, H-11), 2.91
(m, 2H, H-4), 2.25 (s, 3H, H-13) ppm; 13C NMR (CD3OD):
d 169.2 (C5N), 152.5 (C2N), 148.3 (C-60, C-80), 145.6 (C-300),
141.7 (C-100), 134.5 (C-70), 130.4 (C-500), 128.2 (C-100), 124.3
(C-90), 121.6 (C-200), 110.4 (C-600), 105.6 (C-50), 104.2 (C-400),
70.3 (C-30), 65.8 (3 · OCH3), 61 (OCH3), 35.4 (C-40), 26.1,
23.4 ppm; EIMS m/z: 463 M+ (100%), 341, 297, 166, 122.
2.2.17. Synthesis of 5-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-
1H-isochromen-1-yl)-4H-1,2,4-triazole-3-thiones (7a–e),
General procedure
The thiosemicarbazides (3a–g) (1.4 mmol) were reﬂuxed (2–
4 h) in aqueous sodium hydroxide solution (4 N, 25 mL).
The progress of the reaction was monitored by TLC. After
completion of the reaction, the reaction mixture was cooled
to room temperature and ﬁltered. The ﬁltrate was neutralized
with hydrochloric acid (4 N) to precipitate the triazoles-thiones
(7a–e), which were ﬁltered and recrystallized from aqueous
ethanol.
2.2.18. 4-o-Methoxy-5-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-
1H-iso-chromen-1-yl)-4H-1,2,4-triazole-3-thione (7a)
Yield: 78%; semisolid, Rf (Petroleum ether: Ethyl acetate, 4:1):
0.6; Elemental analysis for C23H33N3O5S (MW= 481) in wt%
calc. C = 59.59, H = 7.17, N = 9.06, S = 6.92 and found to
be C = 59.61, H = 7.28, N = 9.13, S = 7.01; FTIR (cm1):
3012, 1589, 1441, 1218, 1H NMR (CD3OD): d 10.39 (bs,
SH), 7.3 (d, 1H Ar, J = 3.2), 7.10 (d, 1H Ar, J= 5.5), 6.93
(d, 1H Ar, J= 3.1), 6.61 (d, 1H Ar, J= 4.1), 6.56 (s, 1H,
H-5), 3.91 (s, 12H, 4 · OCH3), 3.86 (m, 2H, H-3), 3.74(s, 2H, H-11), 2.94 (m, 2H, H-4), 2.11 (s, 3H, H-13), 1.62 (s,
3H, CH3) ppm;
13C NMR (CD3OD); d 160 (C‚S), 158.1
(C-20), 150.6 (CN), 149.6 (C-8), 148.3 (C-6), 136.6 (C-7),
128.7 (C-10), 127.2 (C-60), 121.4 (C-9, C-50), 114.4 (C-30),
75.3 (C-1), 65.2 (OCH3), 60.4 (C-3), 47.3 (CH2), 27.1 (CH3)
ppm;; EIMS m/z: 463 M+ (100%), 356, 341, 297, 165,122, 107.
2.2.19. 4-p-Methyl-5-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-
1H-isochromen-1-yl)-4H-1,2,4-triazole-3-thiol (7b)
Yield: 81%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
0.5; Elemental analysis for C23H33N3O4S (MW= 481) in wt%
calc. C = 61.72, H = 7.43, N = 9.39, S = 7.16 and found to
be C = 61.88, H = 7.59, N = 9.45, S = 7.25; FTIR (cm1):
3122, 1598, 1423, 1247; 1H NMR (CDCl3): d 11.30 (bs, SH),
7.26 (d, 2H Ar, J= 5.1), 7.01 (d, 2H, Ar, J = 4.6), 6.53 (s,
1H, H-5), 3.91 (s, 9H, 3 · OCH3), 3.85 (m, 2H, H-3), 3.69 (s,
2H, H-11), 2.50 (m, 2H, H-4), 2.31 (s, 3H, CH3, H-11), 1.58
(s, 3H, CH3) ppm;
13C NMR (CDCl3): d 161.8 (CS), 152.8
(CN), 149.8 (C-8), 148.1 (C-6), 136.6 (C-7), 129.7 (C-30, C-
50), 128.8 (C-10), 126.9 (C-20, C-60), 121.9 (C-9), 75.0 (C-1),
65.9 (3 · OCH3), 60.7 (C-3), 47.2 (CH2), 27.4 (CH3) ppm;
EIMS m/z: 447 M+ (100%), 356, 298, 149, 91, 66, 55.
2.2.20. 4-p-Methoxy-5-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-
1H-isochromen-1-yl)-4H-1,2,4-triazole-3-thiol (7c)
Yield: 66%; semisolid, Rf (Petroleum ether: ethyl acetate, 1:9):
0.8; Elemental analysis for C23H33N3O5S (MW= 481) in wt%
calc. C = 59.59, H = 7.17, N = 9.06, S = 6.92 and found to
be C = 59.61, H = 7.28, N = 9.13, S = 7.01; IR (cm1):
3127, 1592, 1423, 1256; 1H NMR (CD3OD): d 9.81 (bs, SH),
7.40 (d, H Ar, J= 5.2), 7.33 (d, 2H Ar, J= 5.3), 6.58 (s,
1H, H-5), 3.92 (m, 2H, H-3), 3.84 (s, 12H, 4 · OCH3), 3.72
(s, 2H, H-11), 2.91 (m, 2H, H-4), 2.24 (s, 3H, H-13),
1.58 ppm; 13C NMR (CD3OD): d 160.9 (CS), 149.7 (C-8),
148.5 (C-6), 143.9 (CN), 136.0 (C-7), 129.4 (C-30, C-50), 128.6
(C-10), 126.8 (C-20, C-60), 121.5 (C-9), 75.5 (C-1), 65.3
(3 · OCH3), 62.0 (OCH3), 60.4 (C-3), 47.8 (CH2), 27.3 (CH3)
ppm; EIMS m/z:463 M+ (100%), 356, 341, 297, 165,122, 107.
2.2.21. 4-p-Chloro-5-(6,7,8-trimethoxy-1-methyl-3,4-dihydro-
1H-isochromen-1-yl)-4H-1,2,4-triazole-3-thiol (7d)
Yield: 77%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
0.7; FTIR (cm1): 3011, 1567, 1423, 1247, 1H NMR (CD3OD):
d 9.12 (bs, SH), 7.65 (d, 2H Ar, J = 4.9), 7.51 (d, 2H Ar,
J = 5.1), 6.52 (s, 1H, H-5), 3.90 (s, 9H, 3 · OCH3), 3.85 (m,
2H, H-3), 3.71 (s, 2H, H-11), 2.93 (m, 2H, H-4), 1.90 (s, 3H,
H-13) ppm; 13C NMR (CD3OD): d 158 (CS), 153.8 (CN),
149.0 (C-8), 148.8 (C-6), 136 (C-7), 131.4 (C-40), 130.9 (C-30,
C-50), 129.9 (C-10), 126.1 (C-20, C-60), 121.2 (C-9), 75.2 (C-
1), 65.0 (3 · OCH3), 60.2 (C-3), 47.4 (CH2), 27.3 (CH3) ppm;
EIMS m/z: 467 M+ (100%), 356, 298, 168, 111.
2.2.22. 4-m-Methoxy-5-(6,7,8-trimethoxy-1-methyl-3,4-
dihydro-1H-isochromen-1-yl)-4H-1,2,4-triazole-3-thiol (7e)
Yield: 86%; semisolid, Rf (Petroleum ether: ethyl acetate, 4:1):
0.6; Elemental analysis for C23H33N3O5S (MW= 481) in wt%
calc. C = 59.59, H = 7.17, N = 9.06, S = 6.92 and found to
be C = 59.61, H = 7.28, N = 9.13, S = 7.01; FTIR (cm1):
3117, 1573, 1421, 1245; 1H NMR (CD3OD): d 8.87 (bs, SH),
7.68 (s, 1H), 7.54 (d, 1H, H Ar, J = 4.1), 7.43 (d, 1H Ar,
192 A. Saeed, A. MumtazJ= 4.6), 6.59 (d, 1H Ar, J = 5.1), 6.5 (s, 1H, H-5), 3.9 (s, 9H,
3 · OCH3), 3.87 (m, 2H, H-3), 3.75 (s, 2H, H-11), 2.92 (m, 2H,
H-4), 1.98 (s, 3H, H-11), 1.65 (s, 3H, CH3) ppm;
13C NMR
(CD3OD): d 160.0 (CS), 149.3 (CN), 162.8 (C-30), 149.9 (C-
8), 148.0 (C-6), 140.1 (C-1), 136.4 (C-7), 131.9 (C-40), 129.0
(C-10), 126.7 (C-20, C-60), 121.1 (C-9), 118.7 (C-50), 104.5 (C-
5), 75.0 (C-1), 65.6 (3 · OCH3), 64.6 (OCH3), 60 (C-3), 47.9
(CH2), 27.1 (CH3) ppm; EIMS m/z: 463 M
+ (100%), 356,
341, 297, 165,122, 107.
3. Conclusion
New thiadiazoles and triazoles appended to the isochroman
nucleus via one carbon were synthesized and tested for
antibacterial and antifungal activities. Most of the synthesized
inhibited the growth of all microbial strains, but their effective-
ness varied. The lead compounds were also identiﬁed for both
bioassay.
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